Experiments using phage lambda provided early insights into important molecular mechanisms, including genetic recombination and the control of gene expression. Before recombinant DNA technology, the use of lambda, most particularly lambda transducing phages, illustrated the importance of cloning bacterial genes, already providing some insight into how to use cloned genes to advantage. Subsequently, lambda made significant contributions to recombinant DNA technology, including the early generation of genomic and cDNA libraries. More recently, lambda genes associated with recombination have enabled techniques referred to as 'recombineering' to be developed. These techniques permit the refined manipulation, including mutation, of foreign genes in Escherichia coli and their subsequent return to the donor organism.
Introduction
This brief article cannot do justice to 'The Impact of lambda', but focuses on aspects of particular relevance to the field of genetic engineering, from its origins to the role of lambda gene products in techniques of the 21st Century.
Restriction systems
In 1953, the phenomenon of host-controlled variation in the transmission of bacterial viruses was reported for lambda and P2 phages [1] . Phage lambda, for example, grown on Escherichia coli strain C, formed plaques on E. coli K-12 Key words: bacterial chromosome, cosmid, DNA technology, phage lambda, recombineering, restriction endonuclease. 1 email: Noreen.Murray@ed.ac.uk with low efficiency (10 −4 ) compared with on E. coli C. These esoteric biological experiments laid the foundations for the identification of restriction enzymes and, consequently, the analysis, manipulation and sequencing of genes. Almost a decade elapsed before Arber and Dussoix [2] , working with phage lambda, identified the molecular basis of hostcontrolled variation as the modification of DNA, a prerequisite for the prevention of DNA degradation when a phage was transferred from one strain to another, and, in 1968, Meselson and Yuan [3] reported the purification of the first restriction enzyme, EcoKI, the restriction endonuclease present in E. coli K-12. At this time, the fragments of lambda DNA generated by EcoKI were identified by their reduced mobility in a sucrose gradient; the separation of fragments in a gel came a few years later. Nevertheless, the purification of EcoKI stimulated my husband (Ken Murray) and me to seek to identify the target sequences recognized by EcoKI.
Using genetic approaches, I created a series of phage genomes (hybrids of lambda and its relative ϕ80) each with a single target for EcoKI [4] . My collaborator was experienced in the technique of terminally labelling the 5 ends of DNA molecules and deducing the nucleotide sequence at the terminus [5] . The separation of DNA fragments in a sucrose gradient failed to alert us to the unexpected finding that EcoKI recognizes specific target sequences, but does not generate fragments with unique terminal sequences [6] . We now know that EcoKI binds to unmodified target sequences, but then it translocates along the DNA and cuts it elsewhere, thereby generating fragments of variable length with variable termini. Importantly, the purification of EcoKI had a very constructive influence on Ham Smith. He and his student, Kent Wilcox, had initiated work on the transformation of Haemophilus influenzae and they noticed that this bacterium appeared to degrade the DNA of phage P22, a phage grown in Salmonella. They tested this idea using viscometers. While a cell extract from Haemophilus had no effect on the viscosity of Haemophilus DNA, it readily reduced the viscosity of DNA of phage P22. Smith and Wilcox purified a relevant endonuclease, HindII from the Haemophilus strain [7] . The nucleotide sequence within which HindII cuts the DNA was shown to be rotationally symmetrical [8] . This marked the initiation of revolutionary technology.
At an EMBO meeting organized by Werner Arber in 1972, it became known that the DNA fragments generated by EcoRI and EcoRII, unlike those produced by HindII, have sticky (cohesive) ends. The evidence was published later [9] [10] [11] . This provided the message that breakage of DNA and the covalent linkage of fragments by DNA ligase could be achieved in vitro. Since E. coli could be made competent in the uptake of DNA [12] , the future of this type of experimentation promoted much discussion at the EMBO meeting, particularly from an ethical aspect. Later discussions at a Gordon Conference led to international news (see [13] ).
The use of restriction enzymes in the analysis of DNA was significantly enhanced by the advent of gels for the separation of DNA fragments -both polyacrylamide [14, 15] and agarose [16] . Initially, DNA substrates were labelled with 32 P, and the fragments were visualized by autoradiography, but the introduction of ethidium bromide as a fluorescent stain in 1973 [16] greatly facilitated analyses of DNA fragments, and, before long, Southern transfers could locate specific fragments on the basis of their hybridization with a labelled probe [17] .
The paper by Allet et al. [15] identified six fragments when the linear genome of lambda was digested with EcoRI. Our experiments in which we identified and manipulated the targets for EcoKI in the lambda genome [4] , including the selection of mutations that resulted in the loss of targets, suggested that it would be easy to generate lambda genomes with one or two targets. These could be used as vectors for cloning DNA fragments. Unfortunately, the MRC unit in which I was working was terminated, because Bill Hayes, the Head of our Unit, was to move to Australia. This caused a very significant delay in what turned out to be a very simple project. It took 3 weeks to remove the three targets that remained in a deletion mutant of lambda. In 1974, our first experiments making recombinant molecules in vitro were published [18] .
Transducing phages, Campbell model and gene exchange
Before elaborating on the use of lambda for cloning genes by in vitro technology, I think it appropriate to consider the early importance of lambda in the cloning of genes from the chromosome of its host, E. coli. From the 1950s onwards, derivatives of phage lambda in which phage genes had been replaced by bacterial genes were isolated courtesy of Nature's errors. These phages, termed transducing phages, most particularly λgal, λlac and λtrp phages, not only demonstrated the importance of cloned genes for genetic and molecular analyses, but also contributed to our understanding of bacterial genetics, genetic recombination and gene exchange.
In 1962, in a very influential review [19] , Allan Campbell proposed that the lambda genome could integrate into the bacterial genome at a specific site by a single reciprocal crossover. His model for the production of a lysogenic bacterium envisaged a cross-over between two circular genomes, although this model preceded the physical evidence for circularity. According to the Campbell model, the original genomes could be regenerated by a reversal of the reciprocal cross-over event. In addition, rare 'aberrant' excision events in which the cross-over occurred between a site within the prophage (the integrated phage genome) and one within the bacterial genome could produce a phage that had acquired bacterial genes, i.e. a transducing phage. This explained the origin of λgal phages, because the gal genes of E. coli are close to the site at which the prophage resides.
The normal integration and excision of the lambda genome is now known to occur by site-specific recombination and the aberrant excision by so-called 'illegitimate' recombination events that occasionally occur between sequences with relatively little sequence identity. However, the bacterial DNA within a transducing phage permits homology-dependent recombination between the phage and the bacterium. Hence, integration can occur by a single homology-dependent crossover between bacterial DNA, and exchange of a mutation by two cross-overs that flank the genetic difference. Genes from the gal operon, even gal mutations, were transferred between bacterial strains by λgal phages in the 1950s (see [19] ), but the advent of the Campbell model provided the understanding that enabled the design of an efficient, general method. Figure 1 , copied from the second edition of the classical textbook by Bill Hayes published in 1968 [20] , illustrates the transfer of mutations between the bacterial chromosome and bacterial genes cloned in lambda, or an F factor.
Drug-resistance markers were not necessary for lambda; the phage repressor provides an effective means for the selection of lysogenic cells (the first exchange in Figure 1 ) and the subsequent selection of 'cured' cells (cells that have lost the prophage) (the second exchange in Figure 1) . A lysogenic bacterium is readily selected because the resident prophage maintains the production of repressor molecules (approx. 100 per cell) which serve to repress, i.e. prevent transcription of an incoming lambda, making the cell immune to 'super-infection'. In contrast, a lysogenic cell will die if the resident prophage is induced. Induction of the prophage is easily achieved if the repressor is temperature-sensitive. Using a transducing phage encoding a temperature-sensitive repressor, lysogenic cells are selected by their immunity at 32
• C, and cured cells are subsequently selected as survivors at 42
• C [21] . The principle shown in Figure 1 was adopted in yeast almost as soon as yeast was made competent in the uptake of DNA [22] , and it was subsequently applied to bacterial plasmids, aided by drug-resistance markers and a temperature-sensitive replication system, rather than a temperaturesensitive repressor [23] .
Transducing phages originating from natural events did much more than facilitate gene transfer and complementation tests. λlac phages were key contributors [24] . Clearly, it was much easier to study the interaction of the lambda repressor with its operator sequences than of the lac repressor with its operator. The lambda operator sequences reside within a genome of 4.9 × 10 4 bp; those for lac within the bacterial genome of 4.7 × 10 6 bp. λlac transducing phages emulate the lambda system in that the lac operator is present within the lambda genome, and the phage genome can be amplified. Similarly, the lac repressor was the first bacterial protein to be amplified by gene cloning, again via a λlac phage [25] . It is also noteworthy that the visualization of the lac genes by heteroduplex analyses of lac-transducing phages hit the headlines in 1969 [26] .
In vitro technology greatly simplified the cloning of bacterial genes and made it possible to clone genes irrespective of their origin. The first recombinant DNA molecules made in vitro combined the DNA of a defective lambda phage, λdgal, and SV40 (simian virus 40) [27] ; the first to be propagated were derived from a plasmid [28] . Those from lambda followed shortly afterwards [18, 29, 30] .
Lambda vectors, DNA packaging and cosmids
The lambda genome commonly includes five or six targets for restriction enzymes that recognize a hexanucleotide target sequence (e.g. for EcoRI, HindIII or BamHI). To make lambda vectors, the excess targets were removed by base changes, deletions and substitutions. In addition, segments of non-essential DNA were deleted to make space for foreign DNA (see [31] for a review).
For its role as a vector, it was fortunate that the lambda capsid has some flexibility with respect to the length of genome that it can package. Genomes from 38 to 51 kb in length can be packaged, although there is a preference for DNA of around the normal size (49 kb).
Two major classes of lambda vectors were made: (i) insertion vectors that retain a single target for an endonuclease, and (ii) replacement vectors that retain two targets flanking a dispensable segment of DNA. Deletion of the central fragments leaves a genome that is too small to be packaged.
Recombinant lambda genomes were initially recovered in cells made competent in the uptake of DNA, but studies of phage morphogenesis led to an alternative method in which the genomes were encapsidated in vitro by extracts of phage proteins [32] . In vitro packaging increased the efficiency of recovery dramatically. The first replacement vectors were for use with EcoRI [30] , but eventually there were replacement vectors with more space and a dispensable fragment flanked by 'polylinker' sequences that included the targets for three or more enzymes [33] . These vectors permitted the efficient construction of genomic libraries of 20 kb inserts, while insertion vectors provided an effective way of making cDNA libraries [34, 35] .
The packaging of a lambda genome into a capsid is dependent on a specific segment of DNA that includes cos, the sequence which on cutting generates the cohesive ends of the lambda genome. Two cos sequences separated by 38-51 kb of DNA are required for packaging of the intervening sequence. In vitro packaging was cleverly adapted for use with special plasmids, cosmids, by the incorporation of a cos sequence. Cosmid vectors of 5 kb provided efficient recovery of recombinants containing an insert of approx. 40 kb [36] , hence providing an alternative route for making genomic libraries. In vitro packaging was later used for phage P1 to recover fragments approaching 100 kb!
Amplification of gene products
As mentioned earlier, λlac phages illustrated the use of lambda in the purification of the lac repressor. The amplification relied on a mutant promoter with enhanced efficiency, and the increase in copy number of lambda in the absence of cell lysis [25] . In vivo-derived λtrp phage were also important, particularly in the monitoring of expression from lambda promoters [37, 38] .
In 1976, phage lambda offered very easy routes for achieving significant amplification of the product of a cloned prokaryotic gene. In a lambda vector with a temperaturesensitive repressor, the cloned gene is maintained in single copy at 32
• C, and induction at 42
• C leads to 100 copies of the genome that are kept within the cell if cell lysis is blocked by a phage mutation. Maintenance in single copy reduces instability problems associated with the overproduction of a toxic product. Following induction, transcription of the amplified gene can be achieved from its own promoter or courtesy of a lambda promoter (see [39] for a review).
In the early era of recombinant DNA, we sought to clone genes whose products were not simply of biological interest, but were basic tools for molecular biologists. From phage T4, we cloned the gene encoding DNA ligase [40] 
Figure 2 Expression of foreign genes in lambda
The diagrams show the linear genomes of recombinant lambda phages. Solid arrows indicate the major lambda transcription circuits; the lambda promoters P L , P R and P R are indicated by ᭹, and the broken arrows indicate transcription from the promoter of the foreign gene. The site by which the phage integrates into the bacterial chromosome is indicated by att. Following infection, or induction of a prophage, the ends of the genome will be joined so that transcription initiated at P R (near the right-hand end) will continue through the phage genes in the left half to the foreign gene in the centre. (a) The foreign gene (T4 DNA ligase or polynucleotide kinase) is transcribed from the late promoter of lambda, P R . Cell lysis is blocked by a mutation in gene S and capsid formation by a mutation in gene E. (b) The polA gene of E. coli is transcribed from its own promoter, reinforced initially by transcription from the early lambda promoter, P L . In addition to the block in cell lysis (gene S), expression of the late genes is blocked by a mutation in gene Q. It was shown by Moir and Brammar [38] that a block in gene Q was advantageous to the amplification of the product of the trp operon.
and that for polynucleotide kinase [41] . Amplification of these enzymes relied on transcription from the late promoter of lambda [41, 42] , and a mutation in the phage gene that encoded the capsid (see Figure 2 ). These lysogens provided efficient sources of much used enzymes, both in laboratories and commercially.
We also cloned the polA gene of E. coli in lambda, and obtained approx. 100-fold amplification of DNA polymerase I [43, 44] . In this case, amplification was primarily dependent on a promoter associated with the coding sequence, but it was reinforced by the P L promoter of lambda (see Figure 2) . The polA gene was readily cloned and maintained in lambda, but neither we nor others have been able to clone the wildtype polA gene (the coding sequence and its promoter) in a multicopy plasmid. Our experiments paved the way for Joyce and Grindley [45] to transfer the coding sequence for the Klenow fragment of DNA polymerase to a multicopy plasmid, where they obtained controlled expression from a lambda promoter.
Each of the three major lambda promoters has been incorporated within a plasmid to permit controlled transcription of a cloned gene (see [39] ). Moreover, new 'copy control' plasmids emulate lambda in providing tight control of expression from a cloned gene in single copy and efficient transcription following plasmid amplification (see [39] ).
Recombineering
New technologies (recombineering) now rely on in vivo recombination to make novel combinations of DNA (see [46] ). Essentially, phage recombination systems, from either lambda [47] or its relative Rac [48] , substitute for in vitro breakage and reunion of DNA. Until recently, linear DNA, e.g. the product of PCR, could not serve directly as the donor of a DNA sequence within E. coli because it would be rapidly degraded by ExoV, an activity of the RecBCD enzyme. This problem has been overcome by the controlled use of gam, a lambda gene, the product of which inhibits ExoV [49] . In the presence of Gam, the phage recombination systems work efficiently on short segments of identity (<50 bp) to make recombinant molecules, even when the donor DNA is a linear molecule.
Recombineering in E. coli emulates the methods used in yeast, but offers the important advantage of making DNA readily available for use in other organisms (because the yields of DNA from E. coli are so much higher than from yeast). Cassettes, tagged by a gene specifying resistance to a drug, are targeted to specific sequences within the chromosome, or a plasmid (Figure 3 ). Also, as previously possible in yeast [50] , single-stranded DNA (oligonucleotides) can be used to make mutations in a plasmid. Changes made to mouse DNA cloned in a BAC (bacterial artificial chromosome) vector become available for transfer to the mouse genome. For E. coli, DNA can be subcloned directly from the chromosome, and chromosomal coding sequences can be modified, e.g. by fusion to a marker, a regulatory element, or an extension which provides an affinity tag to facilitate purification of the resulting protein [51] .
Phage lambda thus provides a new range of techniques for the 21st Century.
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